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the dorsal root ganglia after peripheral nerve
injury
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Abstract
Background: We have previously reported that nerve injury-induced neuropathic pain is attenuated in toll-like
receptor 2 (TLR2) knock-out mice. In these mice, inflammatory gene expression and spinal cord microglia actvation
is compromised, whereas the effects in the dorsal root ganglia (DRG) have not been tested. In this study, we
investigated the role of TLR2 in inflammatory responses in the DRG after peripheral nerve injury.
Results: L5 spinal nerve transection injury induced the expression of macrophage-attracting chemokines such as
CCL2/MCP-1 and CCL3/MIP-1 and subsequent macrophage infiltration in the DRG of wild-type mice. In TLR2 knock-
out mice, however, the induction of chemokine expression and macrophage infiltration following nerve injury were
markedly reduced. Similarly, the induction of IL-1b and TNF-a expression in the DRG by spinal nerve injury was
ameliorated in TLR2 knock-out mice. The reduced inflammatory response in the DRG was accompanied by
attenuation of nerve injury-induced spontaneous pain hypersensitivity in TLR2 knock-out mice.
Conclusions: Our data show that TLR2 contributes to nerve injury-induced proinflammatory chemokine/cytokine
gene expression and macrophage infiltration in the DRG, which may have relevance in the reduced pain
hypersensitivity in TLR2 knock-out mice after spinal nerve injury.
Background
A series of studies have demonstrated that activation of
spinal cord glial cells plays an important role in the
development of neuropathic pain after peripheral nerve
injury [1]. Activation of spinal cord glia in the absence
of peripheral nerve injury enhanced pain sensitivity [2],
and inhibition of these cells attenuated pain behavior in
a neuropathic pain model [3,4]. Non-neuronal cells in
the dorsal root ganglia (DRG) have also been implicated
in the development of nerve injury-induced neuropathic
pain [5]. Upon peripheral nerve injury, Schwann cells
are activated and produce proinflammatory cytokines
such as TNF-a and IL-1b [6,7]. In addition, peripheral
immune cells including macrophages and neutrophils
are activated and infiltrate into DRG after peripheral
nerve injury [8-10]. Along with this immune cell infiltra-
tion, various proinflammatory cytokines and chemo-
kines, including TNF-a, IL-1b, and MCP-1, are
expressed in the DRG of injured nerves after peripheral
nerve injury [11,12]. It has been suggested that expres-
sion of these proinflammatory cytokines and chemo-
kines may sensitize primary afferent sensory neurons in
the DRG [13-15]. Thus, it is conceivable that macro-
phage infiltration into the DRG may contribute to the
development of pain hypersensitivity after peripheral
nerve injury. However, the exact role of the infiltrating
macrophages in pain induction and the mechanism of
macrophage infiltration into the injured DRG have not
been clearly elucidated.
Toll-like receptors (TLRs) are pattern-recognition
receptors that recognize pathogen-associated molecular
patterns. In mammals, TLRs detect infectious agents
and trigger an innate immune response in the host
organism [16]. Furthermore, certain TLRs recognize
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endogenous molecules that are released from damaged
cells and tissues, suggesting that TLRs may also function
as receptors detecting cell/tissue damage in the body
[17,18]. It has been suggested that TLR2, TLR3, and
TLR4 play a role in the initiation of neuropathic pain
through the recognition of host-derived endogenous
ligands [19-21]. Based on these reports, it was hypothe-
sized that TLR endogenous ligands released from the
damaged sensory neurons might activate spinal cord glial
cells and thereby enhance pain hypersensitivity. More-
over, it was recently reported that TLR2 and TLR4 sig-
naling induces macrophage activation and infiltration
into injured sciatic nerves and regulates Wallerian degen-
eration [22]. These data suggest that TLR may also regu-
late nerve injury-induced macrophage infiltration into
the DRG and thereby affect pain hypersensitivity. In this
study, we explored this hypothesis using TLR2 knock-out
mice and found that TLR2 facilitates macrophage infiltra-
tion and pain-mediating proinflammatory gene expres-
sion in the DRG after spinal nerve injury.
Results
Macrophages infiltrate into the DRG after peripheral
nerve injury
Although it has been reported that macrophages infiltrate
into injured nerves and the DRG of rats after peripheral
nerve injury [8], macrophage infiltration in mouse DRG
after nerve injury has not been well characterized. There-
fore, we began our study by testing whether macrophages
infiltrate into the DRG after L5 spinal nerve transection
in mice, a well-known mouse neuropathic pain model
[19]. To this end, we injured the L5 spinal nerve of
C57BL/6 (wild-type: WT) mice and at various time
points prepared L5 DRG sections and stained these with
antibody for ionized calcium-binding adaptor molecule 1
(Iba-1), a cell-type specific marker for macrophages in
the DRG [23]. Upon L5 spinal nerve transection, the
number of Iba-1-immunoreactive (IR) cells and the
intensity of the immunoreactivity of each cell was
greatly increased in the DRG ipsilateral to the injury,
indicating macrophage infiltration (Figure 1A). Iba-1
Figure 1 Macrophage infiltration in mouse DRGs was increased after peripheral nerve injury. (A) Upon L5 spinal nerve transection, L5
DRG tissues (ipsi- and contralateral) were obtained at various time points (n = 4 for each time point). DRG tissue sections were stained with
anti-Iba-1 antibody. Scale bar: 50 μm. (B) The Iba-1-IR macrophage infiltration in ipsi- and contralateral DRGs of the injured peripheral nerve were
quantified by measuring the intensity of Iba-1-immunoreactivity. Data are presented as mean ± SEM. (#, p < 0.05; ##, **, p < 0.01; #, ##, naïve
(control) vs. 1, 3, 7, and 14 dpi mice; **, ipsilateral vs. contralateral).
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immunoreactivity was also increased in the contralateral
DRG with much less intensity compared to the ipsilateral
DRG, which is in line with a previous report [24]. The
infiltration of Iba-1-IR macrophages into DRGs was pro-
minent on day 3, peaked on day 7, and then decreased on
day 14 post-injury (dpi) (Figure 1B). In sham-operated
mice, macrophage infiltration levels in both the ipsi- or
contralateral DRG were comparable to the levels in con-
trol mice (data not shown).
TLR2 contributes to macrophage infiltration in the DRG
after peripheral nerve injury
To assess the role of TLR2 in nerve injury-induced
macrophage infiltration in the DRG, we quantified
macrophage infiltration in the DRG of WT and TLR2
knock-out mice. Macrophages were separately immu-
nostained using anti-Iba-1 and anti-CD68 antibodies,
two typical macrophage-specific markers (Figure 2A and
2C). The former is used to stain microglia in the CNS,
Figure 2 Spinal nerve injury-induced macrophage infiltration in DRGs is reduced in TLR2 knock-out mice. (A and C) L5 DRGs of sham-
operated WT (WT Sham), TLR2 knock-out (TLR2 Sham), and nerve-injured WT and TLR2 knock-out mice (n = 3) at 7 dpi were stained with anti-
Iba-1 and anti-CD68 antibodies. Iba-1 or CD68 immunoreactivities (green) were merged with NeuN-IR (red) neurons in DRG. Low magnification
images (75x) of DRG tissue are shown as subsets in each panel. The expression levels of Iba-1 and CD68 were quantified by measuring the
fluorescence intensity (B and D). Scale bars: 50 μm. Data are presented as mean ± SEM. (*, p < 0.05; ##, **, p < 0.01; ##, sham vs. 7 dpi mice; *, **,
WT vs. TLR2 knock-out mice).
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but detects macrophages in the DRG [25]. With both
staining methods, the number of L5 DRG-infiltrating
macrophages after spinal nerve injury was significantly
decreased in the TLR2 knock-out mice compared with
WT mice. Quantitatively, the intensity of Iba-1 and
CD68 staining observed in the TLR2 knock-out DRGs
were only 26 ± 2% and 43 ± 13% that of WT DRGs,
respectively (Figure 2B and 2D). Sections were also
stained with NeuN antibody, a neuronal cell marker, to
confirm that the samples represented DRG and not
spinal nerve tissues (Figure 2A and 2C).
Peripheral nerve injury-induced expressions of CCL2/MCP-
1 and CCL3/MIP-1a in the DRG are reduced in TLR2
knock-out mice
Recent studies show that proinflammatory chemokines
are expressed in the DRG after peripheral nerve injury,
which may be responsible for the recruitment of
immune cells [26,27]. To investigate the molecular
mechanisms of macrophage infiltration into the DRG,
we measured the expression of various chemokines that
are implicated in immune cell recruitment in the DRG
of injured nerves by real-time RT-PCR. We observed
induction of CCL2/MCP-1, CCL3/MIP-1a, and CXCL1/
GRO-a mRNA expression in the L5 DRG at early time
points (6 h post-injury), whereas expression of CCL5
and CXCL10 were induced later (48 h post-injury)
(Table 1). Since CCL2/MCP-1 and CCL3/MIP-1a are
potent monocyte/macrophage chemo-attractants [28,29]
and are significantly induced in the L5 DRG after nerve
injury (20-fold and 8-fold, respectively), we tested
whether these chemokines are differentially expressed in
WT vs. TLR2 knock-out mice. Our data show that
nerve injury-induced CCL2/MCP-1 expression was
markedly attenuated in the TLR2 knock-out DRG (20.9
± 3.6 fold in WT mice vs. 5.5 ± 0.5 fold in TLR2 knock-
out mice at 6 h post-injury) (Figure 3A). Likewise,
CCL3/MIP-1a expression was reduced in the DRG of
TLR2 knock-out mice (8.0 ± 1.6 fold in WT mice vs.
3.1 ± 1.0 fold in TLR2 knock-out mice) (Figure 3B).
These data suggest that reduced chemokine expression
in the DRG of nerve-injured TLR2 knock-out mice may
at least partly account for the reduced macrophage infil-
tration in the DRG of these mice.
To determine the cell types expressing CCL2/MCP-1,
DRG sections were immunostained with anti-CCL2/
MCP-1 antibody and anti-NeuN antibody or anti-S100
antibody (satellite glial cell marker). It has been pre-
viously reported that CCL2/MCP-1 expression is
increased in DRG neurons after peripheral nerve injury
[12]. In accordance with this previous study, we found
that CCL2 was predominantly expressed in NeuN-IR
neurons of the DRG (Figure 4A), but not in S100-IR
satellite glial cells (data not shown). However, TLR2-IR
was not co-localized to MAP2-IR neurons (Figure 4B.
a, b, and 4B. 4c); instead, TLR2 expression was
detected in cells surrounding the neuronal cell body.
The specificity of the TLR2 antibody used was con-
firmed by staining DRG tissues from TLR2 knock-out
mice (Additional file 1, Supplemental Fig. 1). These
TLR2+ cells were morphologically identifiable as satel-
lite glial cells [30], and also merged with GFAP-IR in
the DRG of nerve-injured mice (Figure 4B. d, e, and
4B. 4f). In addition, some Iba-1-IR macrophages that
Table 1 Chemokine gene expression in DRGs after L5
spinal nerve injury
DRG CCL2 CCL3 CCL5 CXCL1 CXCL10
6 h 20.9 ± 3.6* 8.0 ± 1.6* 0.7 ± 0.3 5.8 ± 0.5** 0.6 ± 0.2
24 h 7.0 ± 0.9* 4.2 ± 0.2** 0.8 ± 0.0 2.2 ± 0.4* 1.1 ± 0.3
48 h 4.1 ± 0.2** 4.1 ± 0.5* 2.5 ± 0.2* 2.7 ± 0.1** 2.9 ± 0.6
Total RNA was prepared from each DRG at various time points after L5 spinal
nerve injury and used for real-time RT-PCR to measure the mRNA expression
of chemokines. Data are presented as mean ± SEM (*, p < 0.05; **, p < 0.01).
Figure 3 Spinal nerve injury-induced expression of CCL2/MCP-
1 and CCL3/MIP-1a in DRGs is reduced in TLR2 knock-out
mice. (A and B) DRG tissues were obtained from ipsilateral L5 spinal
nerve of un-injured naïve mice (control; n = 5), injured WT mice
(WT; n = 5), and injured TLR2 knock-out mice (TLR2; n = 5) at 6, 12,
and 24 h post-injury. Total RNA was isolated from pooled DRG
tissues of each group, and CCL2/MCP-1 and CCL3/MIP-1a mRNA
expression was measured by real-time RT-PCR. The expression level
of each gene was normalized to the level of the GAPDH gene and
presented as fold-induction compared with uninjured naïve mice.
The experiments were independently performed twice and the data
presented as mean ± SEM. (#, p < 0.05; ##, p < 0.01; naïve (control)
mice vs. 6, 24, and 48 h post-injury; *, p < 0.05; **, p < 0.01, WT vs.
TLR2 knock-out mice).
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also merged with TLR2-IR were detected in the DRG
of uninjured control mice (Figure 4B. g, h, and 4B. i).
Notably, TLR2 expression in the DRG was further
upregulated after spinal nerve injury, and continued to
be detected mainly in satellite glial cells and macro-
phages but not in neurons (Additional file 2, Supple-
mental Fig. 2). Taken together, these data suggest that
expression of TLR2 in satellite glial cells and macro-
phages in the DRG may somehow affect CCL2 expres-
sion in neurons and macrophage infiltration into the
DRG after spinal nerve injury.
TLR2 contributes to peripheral nerve injury-induced TNF-
a and IL-1b expression in the DRG and to the
development of spontaneous pain behavior
Previously, we reported that TLR2 contributes to pain
hypersensitivity after L5 spinal nerve injury [20]. It is
also known that peripheral nerve injury induces the
expression of proinflammatory cytokines, such as TNF-
a and IL-1b, in the DRG and that these cytokines may
play a role in the development of pain hypersensitivity
[13,14]. To test whether there is any correlation between
nerve injury-induced cytokine expression in the DRG
and the levels of pain hypersensitivity in WT and TLR2
knock-out mice, we measured the mRNA expression
levels of TNF-a and IL-1b in the DRG of injured nerves.
Upon L5 nerve transection, the expression of TNF-a
and IL-1b transcripts in the DRG of WT mice increased
by 5.3 ± 0.6 and 9.1 ± 0.9 fold, respectively, compared
with 1.7 ± 0.3 and 4.2 ± 0.5 fold in the DRG of TLR2
knock-out mice (Figure 5A). The protein expression of
these cytokines was confirmed by ELISA, which showed
that the induction of TNF-a and IL-1b protein follow-
ing nerve injury was significantly reduced in the DRG of
TLR2 knock-out mice compared to that of WT mice
(Figure 5B).
Previous studies have shown that TNF-a is expressed
in neurons and satellite cells in the DRG after nerve
injury [26]. We have also detected TNF-a expression in
a subset of DRG neurons after spinal nerve transection
(data not shown). However, the cells that express IL-1b
in the DRG after peripheral nerve injury have not been
identified. In this study, we found that the IL-1b-expres-
sing cells co-stained mainly with CD68-IR macrophages
in WT DRG at 7 days after spinal nerve injury (Figure
5C), indicating expression of IL-1b by macrophages.
The reduced expressions of these cytokines in the DRG
of the L5 spinal nerve-injured TLR2 knock-out mice
were accompanied by a reduction of nerve injury-
induced spontaneous pain as assessed by foot lifting
behavior (Figure 5D). At 14 days after peripheral nerve
injury, the duration of spontaneous foot lifting during a
5-min period increased to 20 sec in WT mice, whereas
it was attenuated by more than 50% in TLR2 knock-out
mice (Figure 5D). Collectively, these data show that
expression of TNF-a and IL-1b is reduced in the DRG
of nerve injured-TLR2 knock-out mice compared with
WT mice, which may be relevant in the reduction of
nerve injury-induced spontaneous pain hypersensitivity
observed in the TLR2 knock-out mice.
Discussion
Neuropathic pain often develops following peripheral
nerve damage. In this pathological condition, peripheral
immune cells including macrophages and T cells infil-
trate into the damaged peripheral nerve [31] and the
Figure 4 Characterization of TLR2 and CCL2 expression in DRG
cells. (A) CCL2 is expressed in DRG neurons after nerve injury. DRGs
of un-injured WT mice (WT Sham; a, b, and c), injured WT mice at 1
dpi (WT; d, e, and f), and injured TLR2 knock-out mice (TLR2 KO; g,
h, and i) at 1 dpi were immunostained with anti-NeuN antibody
(shown in red, a, d, and g) and anti-CCL2/MCP-1 antibody (shown
in green, b, e, and h). Merged images are shown in the right panels.
(B) TLR2 immunoreactivity (red color in a, d, and g) merged with
GFAP-IR satellite cells (e) in DRG at 7 dpi, and to Iba-1-IR
macrophages (h) in un-injured DRGs, but not to MAP2-IR neurons
(b). Merged images are shown in the right panels (c, f, and i). The
triangles indicate double-positive cells. Scale bars: 50 μm.
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adjacent DRG [8,9,32]. At the same time, proinflamma-
tory cytokines and chemokines are upregulated in the
DRG associated with the injured nerves [33]. However,
the mechanisms underlying this nerve injury-induced
macrophage infiltration and proinflammatory cytokine/
chemokine induction in the DRG have not yet been elu-
cidated. In the present study, we demonstrated that
TLR2 plays important roles in nerve injury-induced
macrophage infiltration in the DRG after peripheral
nerve injury. We also found increased expression of sev-
eral chemokines, including CCL2/MCP-1 and CCL3/
MIP-1a, in the DRG of injured WT mice, whereas this
expression was attenuated in TLR2 knock-out mice. The
difference in the expression levels of macrophage-
attracting chemokines after nerve injury between WT
and TLR2 knock-out mice may account for the
decreased macrophage infiltration in the TLR2 knock-
out DRG. Previous studies have shown that CCL2/
MCP-1 is expressed in DRG sensory neurons after per-
ipheral nerve injury [27,34]. In accordance with these
reports, we demonstrated CCL2/MCP-1 expression in
DRG neurons of injured nerves; in fact, among the che-
mokines expressed in the DRG, CCL2/MCP-1 was the
most significantly upregulated after nerve injury at early
time points. This finding raised the possibility that
TLR2 expressed in injured DRG neurons may directly
regulate CCL2/MCP-1 expression in this cell type. This
is consistent with a previous report showing TLR4
expression in the sensory neurons of rat trigeminal
ganglia [35]. However, in our immunohistochemical stu-
dies we failed to detect TLR2 expression in any of the
DRG neurons; instead, we observed TLR2 expression in
GFAP+ satellite glia and Iba-1+ macrophages in the
DRG. Based on these data, we reasoned that TLR2-
expressing satellite glial cells or macrophages in the
DRG might respond to nerve injury and indirectly
induce CCL2/MCP-1 expression in DRG neurons after
peripheral nerve injury, thus enhancing macrophage
infiltration.
It is not clear how TLR2 expressed on satellite glial
cells and macrophages in the DRG recognizes or
responds to peripheral nerve injury. Although purely
speculative, it can be conjectured that certain TLR2
endogenous ligand(s) are released from the damaged
DRG neurons after spinal nerve injury, which in turn
activate TLR2 on nearby satellite glial cells or macro-
phages. To date, several endogenous TLR agonists have
Figure 5 Spinal nerve injury-induced expression of
proinflammatory cytokines in DRGs and spontaneous pain are
attenuated in TLR2 knock-out mice. (A) Total RNA was isolated
from pooled L5 DRGs of WT and TLR2 knock-out mice with or
without L5 spinal nerve transection (n = 5, each group). TNF-a and
IL-1b gene expression was measured by real-time RT-PCR and
presented as fold induction compared with the sham control group.
Means ± SEM of two independent experiments are shown (*, p <
0.05, WT vs. TLR2 knock-out mice; ##, p < 0.01; sham vs. 48 h post-
injury mice). (B) TNF-a and IL-1b protein expression in DRGs were
measured by ELISA. Proteins were prepared from pooled DRG
tissues of WT and TLR2 knock-out mice with or without L5 spinal
nerve transection (n = 5, each group). Means ± SEM of two
independent experiments are shown (*, p < 0.05, WT vs. TLR2
knock-out mice; ##, p < 0.01; sham vs. 7 dpi mice). (C) IL-1b
expression was detected in DRG macrophages. DRG tissues at 7 dpi
were immunostained with anti-CD68 (a) and anti-IL-1b antibody (b).
Merged images are shown in the right panels (c). Low
magnification images (75×) of DRG tissue are shown as subsets in
each panel. Scale bar: 50 μm. (D) Spontaneous pain in nerve-injured
WT and TLR2 knock-out mice was measured using foot lifting
behavior following L5 spinal nerve transection. The duration of
spontaneous foot lifting was measured in WT mice (WT; n = 6) and
TLR2 knock-out mice (TLR2; n = 6). Data were presented as mean ±
SEM (*, P < 0.05; WT vs. TLR2 knock-out mice).
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been reported; for example, TLR2 and TLR4 recognize
molecules released from damaged cells/tissues including
heat shock proteins, HMGB-1, and hyaluronic acid, and
thereby transmit a “danger signal” in the innate immune
cells [17,18]. In addition, TLR3 is known to bind to
mRNA released from necrotic cells [36]. Therefore, it
will be interesting to test whether any of these endogen-
ous TLR agonists are released in the DRG after periph-
eral nerve injury. In line with these reports, it is notable
that all of these TLR members are implicated in nerve
injury-induced pain hypersensitivity [19-21].
We previously showed that nerve injury-induced acti-
vation of spinal cord microglia and subsequent pain
hypersensitivity is attenuated in TLR2 knock-out mice,
suggesting a putative role of microglial TLR2 in nerve
injury-induced neuropathic pain. The data from this
study suggest that TLR2 on satellite glial cells and
macrophages in the DRG may also be involved in nerve
injury-induced pain hypersensitivity. At present, it is not
clear whether microglial TLR2 and TLR2 on DRG cells
(macrophages and/or satellite glia) contribute indepen-
dently to nerve injury-induced pain hypersensitivity.
Moreover, the relative contribution of these two cell
populations to pain induction has not been elucidated.
Of note, there is a slight difference in the kinetics of
cell activation and infiltration in the spinal cord and
DRG after nerve injury; DRG infiltration of macro-
phages after nerve injury peaks at 7 dpi, whereas nerve
injury-induced spinal cord microglia activation peaks at
4 dpi [20]. Considering this, we think it is less likely
that TLR2-mediated macrophage infiltration in the
DRG affects the rate of spinal cord microglia activation
after spinal nerve injury. Recently, Shi et al. argued that
TLR2-mediated macrophage infiltration in injured
nerves plays a critical role in the development of neuro-
pathic pain [37]. They contended that the effects of
TLR2 on microglia activation are minimal based on
their observation of a similar level of spinal cord micro-
glia activation in WT vs. TLR2 knock-out mice after
nerve injury. In this study, however, they measured
spinal cord microglia activation only at 14 dpi, at which
point nerve injury-induced spinal cord microglia activa-
tion largely subsides [19]. In contrast, we observed a
significant difference in spinal cord microglia activation
in TLR2 knock-out mice compared to WT mice at 4
and 7 dpi [20]. Additionally, Shi et al. showed that
macrophage infiltration in injured nerves peaks at 14
dpi [37]. In contrast, in our study macrophage infiltra-
tion in the DRG peaked at 7 dpi, whereas the infiltra-
tion rate at 3 dpi and 14 dpi was comparable (Figure
1B). Such differences in the kinetics of macrophage
infiltration suggest that it is less likely that TLR2 effects
on the DRG are secondary to their effects on injured
nerves.
In addition to its role in nerve injury-induced
mechanical allodynia and thermal hyperalgesia [20], in
this study we report for the first time that TLR2 is also
involved in spontaneous pain induction after nerve
injury. Spontaneous pain may arise as a result of ectopic
action potential generation within the neuronal cell
body of the damaged DRG and/or neuroma [38]. Inter-
estingly, many studies have demonstrated that proin-
flammatory cytokines and chemokines can directly
activate or sensitize pain-mediating sensory neurons in
the DRG. For example, CCL-2/MCP-1 increases the
excitability of nociceptive neurons by transactivating
TRPV1 channels [39]. CXCL-1 has also been shown to
regulate excitability of DRG neurons by regulating their
sodium and potassium currents [40,41]. Likewise, excita-
tory effects of TNF-a and IL-1b on nociceptive DRG
neurons have been reported [13,14]. These previous
reports suggest that the expression of these cytokines/
chemokines in the DRG after peripheral nerve injury
may activate or sensitize nociceptive neurons in the
DRG and thereby induce pain hypersensitivity. Thus,
our study, in conjuction with a study by Shi et. al. [37],
suggests that the attenuated induction of spontaneous
pain observed in TLR2 knock-out mice may be attribu-
ted to the decreased expression of proinflammatory
genes in the DRG or injured nerve. Of interest, we also
detected macrophage infiltration in L4 DRGs after L5
nerve injury, although the infiltration rate was much
lower than that for L5 DRG (data not shown). This sug-
gests the possibility that macrophage infiltration into
non-injured DRG may affect neuropathic pain induction,
a hypothesis which was not further investigated in this
study.
Conclusions
In conclusion, our study demonstrates that TLR2 contri-
butes to macrophage infiltration and proinflammatory
cytokine/chemokine gene expression in the DRG of
injured nerves after spinal nerve injury. These data illus-
trate putative mechanisms underlying nerve injury-
induced immune cell infiltration and proinflammatory
cytokine/chemokine expression in the DRG.
Methods
Animals and Surgery
All animal experiments were performed in male mice
ranging in age from 8 to 10 weeks and weighing 20 to
25 g. All mice were housed in an animal facility with a
specific pathogen-free barrier at a temperature of 23°C.
They experienced a 12-h light-dark cycle and were fed
food and water ad libitum. TLR2 knock-out mice that
had been backcrossed to C57BL/6 background for more
than 10 generations were obtained from Dr. S. Akira
(Osaka University, Japan); C57BL/6 mice (Orient Bio,
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South Korea) were used as WT control. The L5 spinal
nerve was transected as previously described [20] with
minor modification. We anesthetized animals with
sodium pentobarbital (50 mg/kg, i.p.) and removed the
L6 transverse process to identify the L4 and L5 spinal
nerves. The L5 spinal nerve was then isolated and trans-
ected. The wound was irrigated with saline and closed
with surgical skin staples. All animal experimental pro-
cedures were performed according to guidelines from
the International Association for the Study of Pain
(IASP) and were approved by the Institutional Animal
Care and Use Committee (IACUC) of Seoul National
University.
Behavioral testing
Spontaneous pain was measured using spontaneous
foot lifting behavior following L5 spinal nerve transec-
tion, as previously described [42]. Following L5 spinal
nerve injury, mice were placed under a transparent
plastic cover (15 cm × 15 cm) and adapted for 20 min.
After adaptation, the duration of spontaneous foot lift-
ing was measured for 5 min. Foot lifts associated with
locomotion or repositioning of the body were not
counted. Average scores were recorded in duplicate
trials. The behavioral tests were performed in a
blinded fashion.
Real-time RT-PCR
Real-time RT-PCR was performed as previously
described [20] using an ABI Prism 7500 sequence
detection system and a Power SYBR Green reagents kit
(Applied Biosystems, Foster City, CA, USA). The
sequences of the primers used are presented in Table
2. The level of each gene was normalized to that of
the mouse GAPDH gene and represented as a fold
induction, which was calculated using the 2-ΔΔCt
method described elsewhere [43]. All real-time RT-
PCR experiments were performed at least three times;
the mean ± SEM values have been presented unless
otherwise noted.
Immunofluorescence analysis
Mice were deeply anesthetized with sodium pentobarbi-
tal (50 mg/kg) and then sacrificed by transcardial perfu-
sion with 4% paraformaldehyde in 0.1 M phosphate
buffer at either 1, 3, 7, or 14 days after surgery. The
DRGs associated with injured nerves were removed by
laminectomy, post-fixed at 4°C overnight, and then
transferred to 30% sucrose in PBS for 48 h. Transverse
sections (10 μm thick) of DRGs were prepared on gela-
tin-coated glass slides using a cryocut microtome (Leica
CM3050S, Germany). The slides were blocked in solu-
tion containing 5% normal donkey serum, 2% bovine
serum albumin, and 0.1% Triton X-100 for 1 h at room
temperature (RT), incubated overnight at 4°C with rab-
bit anti-Iba-1 antibody (1:2,000, Wako, Japan) [44,45] or
rat anti-CD68 antibody (1:500, Serotec, Oxford, UK)
[46,47] for macrophage staining, and finally incubated
with goat anti-CCL2/MCP-1 antibody (1:200, R&D Sys-
tems, Minneapolis, MN, USA) [48], mouse anti-NeuN
antibody (1:1000, Chemicon, Temecula, CA, USA),
mouse anti-TLR2 antibody (1:100, eBioscience, San
Diego, CA, USA), rabbit anti-MAP2 antibody (1:2,000,
Millipore, Bedford, MA, USA), rabbit anti-GFAP anti-
body (1:10,000, DAKO, Glostrup, Denmark) [49,50], and
goat anti-IL-1b antibody (1:100, R&D Systems) [51].
The sections were then incubated for 1 h at RT with a
mixture of FITC-conjugated and Cy3-conjugated sec-
ondary antibodies (1:200, Jackson ImmunoResearch, Bar
Harbor, ME, USA). The sections were mounted on
slides using Vectashield mounting medium (Vector
Laboratories, Burlingame, CA, USA) and fluorescent
images were obtained with a confocal microscope (LSM
5 Pascal, Carl Zeiss, Germany). At each time point, L5
DRGs were prepared from more than three WT and
TLR2 knock-out mice. Three sections per DRG were
stained, and three fields (100 μm × 100 μm) were
selected in each stained DRG section. The intensities of
Iba-1 and CD68 staining were quantified using ImageJ
software (NIH Image, Bethesda, MD, USA) as described
elsewhere [52].
Table 2 Primers used for real-time RT-PCR
Genes Forward primers Reverse primers GenBank no.
mouse GAPDH 5’-AGG TCA TCC CAG AGC TGA ACG-3’ 5’-CAC CCT GTT GCT GTA GCC GTA T-3’ NM_008084
mouse CD11b 5’-TAA TGA CTC TGC GTT TGC CCT G-3’ 5’-ATT GGA GCT GCC CAC AAT GAG-3’ NM_008401
mouse TNF-a 5’-AGC AAA CCA CCA AGT GGA GGA-3’ 5’-GCT GGC ACC ACT AGT TGG TTG T-3’ NM_013693
mouse IL-1b 5’-TTG TGG CTG TGG AGA AGC TGT-3’ 5’-AAC GTC ACA CAC CAG CAG GTT-3’ NM_008361
mouse CCL2 5’-TCA GCC AGA TGC AGT TAA CG-3’ 5’-GAT CCT CTT GTA GCT CTC CAG C-3’ BC05507
mouse CCL3 5’-ACT GCC TGC TGC TTC TCC TAC A-3’ 5’-AGG AAA ATG ACA CCT GGC TGG-3’ BC111443
mouse CCL5 5’-CTC ACC ATC ATC CTC ACT GCA-3’ 5’-GCA CTT GCT GCT GGT GTA GAA A-3’ AY722103
mouse CXCL1 5’-CAC ACT CAA GAA TGG TCG CGA-3’ 5’-TTG TCA GAA GCC AGC GTT CAC-3’ BC132502
mouse CXCL10 5’-TGC CGT CAT TTT CTG CCT CA-3’ 5’-TCA CTG GCC CGT CAT CGA TAT-3’ BC030067
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Enzyme-linked immunsorbant assay (ELISA)
DRG tissues were collected from WT and TLR2 knock-
out mice after L5 spinal nerve transection or a sham
operation. Tissue lysates were prepared from the DRGs
using a micro tissue grinder (Wheaton, Millville, NJ,
USA) in 200 μl RIPA buffer (50 mM Tris-HCl, 150 mM
NaCl, 1% SDS, 1% Nonidet P-40, 0.5% sodium deoxy-
cholate, 20 mM EGTA) containing protease inhibitors
(Calbiochem, La Jolla, CA, USA). The DRG lysates were
centrifuged at 12,000 rpm for 5 min to remove tissue
debris; the total protein concentration of the lysates was
measured using a Bio-Rad protein assay kit (Hercules,
CA, USA). Mouse TNF-a and IL-1b protein was quanti-
fied using TNF-a and IL-1b ELISA kits (Biosource,
Camarillo, CA, USA), respectively, according to the
manufacturer’s instructions.
Statistical Analysis
Data are represented as mean ± SEM. The statistical sig-
nificance of differences was analyzed using the PASW
statistical program (SPSS Inc., Chicago, IL, USA). Statis-
tical analyses were performed using the Student’s t test
or one-way or two-way ANOVA followed by Tukey’s
post hoc tests. A p value less than 0.05 was considered
to be statistically significant.
Additional material
Additional file 1: Supplemental Figure 1. TLR2 immunoreactivity is
detected in DRG of WT mice, but not of TLR2 knock-out mice. (a
and b) To confirm TLR2 antibody specificity, L5 DRGs of un-injured WT
and TLR2 knock-out mice were stained with anti-TLR2 antibody. Scale
bar: 50 μm.
Additional file 2: Supplemental Figure 2. TLR2 expression is
increased in DRG after L5 spinal nerve transection. (A) L5 DRGs were
isolated from un-injured and L5 spinal nerve-injured mice at 3 and 7 dpi.
The isolated DRGs were stained with anti-TLR2 (red color in a, d, and g)
and anti-Iba-1 (green color in b, e, and h) antibodies. Merged images are
shown on the right. Scale bar: 50 μm. (B) Total RNA was isolated from
pooled L5 DRGs of WT mice with or without L5 spinal nerve transection
(n = 5, each group). TLR2 gene expression was measured by real-time
RT-PCR and presented as fold induction compared with the un-injured
control group. Means ± SEM of two independent experiments are shown
(*, p < 0.05; Control vs. each time point).
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